Evolent Health (STU:9EH) Debt-to-Equity : 0.71 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evolent Health Debt-to-Equity?

Evolent Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €189 Mil. Evolent Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €492 Mil. Evolent Health's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €956 Mil. Evolent Health's debt to equity for the quarter that ended in Dec. 2024 was 0.71.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Evolent Health's Debt-to-Equity or its related term are showing as below:

STU:9EH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.12 Med: 0.4 Max: 0.71
Current: 0.71

During the past 12 years, the highest Debt-to-Equity Ratio of Evolent Health was 0.71. The lowest was 0.12. And the median was 0.40.

STU:9EH's Debt-to-Equity is ranked worse than
62.77% of 556 companies
in the Healthcare Providers & Services industry
Industry Median: 0.45 vs STU:9EH: 0.71

Evolent Health Debt-to-Equity Historical Data

The historical data trend for Evolent Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Debt-to-Equity Chart

Evolent Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.58

0.40

0.55

0.60

0.71

Evolent Health Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															0.60	0.61	0.60	0.61	0.71

Competitive Comparison of Evolent Health's Debt-to-Equity

For the Health Information Services subindustry, Evolent Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolent Health's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Evolent Health's Debt-to-Equity falls into.

Evolent Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Evolent Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(189.266	+	492.292)	/	956.202
	=	0.71

Evolent Health's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(189.266	+	492.292)	/	956.202
	=	0.71

Evolent Health (STU:9EH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Evolent Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Evolent Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

EVH:USA 9EH:Germany

Address

1812 N. Moore Street, Suite 1705, Arlington, VA, USA, 22209

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Evolent Health Headlines

No Headlines